VANGUARD GROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,121,009
+5.5%
1,020,317
+1.0%
0.00%
Q2 2023$15,287,599
+13.5%
1,009,749
+8.7%
0.00%
Q1 2023$13,465,642
+8.2%
928,665
+0.9%
0.00%
Q4 2022$12,441,821
-9.3%
920,253
+5.8%
0.00%
Q3 2022$13,714,000
+47.7%
870,147
+14.1%
0.00%
Q2 2022$9,285,000
+129.8%
762,364
+77.1%
0.00%
Q1 2022$4,041,000
-44.4%
430,404
+1.3%
0.00%
Q4 2021$7,274,000424,9520.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders